SLU Studies New Smallpox Vaccine
30 June 2010
Saint Louis University
As concern continues about the potential use of smallpox in a
terrorist attack, Saint Louis University's Center for Vaccine
Development will lead a National Institutes of Health (NIH)-funded
study of a new vaccine (IMVAMUNE®) to protect against the
deadly disease.
The National Institute of Allergy and Infectious Diseases, part
of the NIH, is funding the research that explores whether a single
injection of a high-dose vaccine against smallpox provides better
protection against the disease than two lower-dose injections of
the vaccine given a month apart.
Full article
DISCLAIMER
The links and content above are provided for your convenience to provide further information and do not constitute an endorsement by Bavarian Nordic. We have no control over the nature, content and availability of the sites that are being linked to and thus we assume no responsibility for the privacy practices on such websites.
